Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04506554
What this trial is testing

Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Fox Chase Cancer Center 81
Large-scale testing (Phase 3)Active Not RecruitingNCT04700124
What this trial is testing

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

Who this might be right for
Bladder Cancer
Merck Sharp & Dohme LLC 808
Early research (Phase 1)Looking for participantsNCT05519241
What this trial is testing

A Phase I Intravesical PPM Therapy for NMIBC

Who this might be right for
Non-muscle-invasive Bladder Cancer
VA Office of Research and Development 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT06305767
What this trial is testing

A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)

Who this might be right for
Bladder Cancer
Merck Sharp & Dohme LLC 230
Testing effectiveness (Phase 2)UnknownNCT05108077
What this trial is testing

Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells

Who this might be right for
Bladder CancerRenal Cancer
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 20
Testing effectiveness (Phase 2)Study completedNCT00041106
What this trial is testing

Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer

Who this might be right for
Metastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
National Cancer Institute (NCI) 50
Not applicableStudy completedNCT05290623
What this trial is testing

High-power Green-light Laser Endoscopic Submucosal Dissection for Non-muscle-invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Shandong Provincial Hospital 45
Early research (Phase 1)Ended earlyNCT03915405
What this trial is testing

KHK2455 (IDO Inhibitor) Plus Avelumab in Adult Subjects With Advanced Bladder Cancer

Who this might be right for
Urothelial Carcinoma
Kyowa Kirin, Inc. 16
Testing effectiveness (Phase 2)UnknownNCT03759496
What this trial is testing

Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Hellenic GenitoUrinary Cancer Group 39
Not applicableLooking for participantsNCT04979156
What this trial is testing

LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors

Who this might be right for
Bladder CancerSurgery
University of Kansas Medical Center 20
Not applicableStudy completedNCT02800473
What this trial is testing

Validation of Endoscopic Bimodal Imager for the Bladder Cancer Detection

Who this might be right for
Bladder Cancer
Institut de Cancérologie de Lorraine 10
Large-scale testing (Phase 3)Study completedNCT01920269
What this trial is testing

Intravesical Adjuvant Electromotive Mitomycin-C

Who this might be right for
Bladder Cancer TNM Staging Primary Tumor (T) TaBladder Cancer TNM Staging Primary Tumor (T) T1Bladder Cancer Transitional Cell Grade
University of Rome Tor Vergata 331
Testing effectiveness (Phase 2)Ended earlyNCT03498196
What this trial is testing

A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerMetastatic Bladder CancerInvasive Bladder Cancer
Baylor College of Medicine 1
Testing effectiveness (Phase 2)Study completedNCT04311580
What this trial is testing

Intravesical Electromotive Mitomycin After Bacillus Calmette-Guérin Failure

Who this might be right for
Bladder Cancer
University of Rome Tor Vergata 52
Large-scale testing (Phase 3)Study completedNCT00622973
What this trial is testing

USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases

Who this might be right for
Prostate CancerBladder Cancer
Insel Gruppe AG, University Hospital Bern 130
Testing effectiveness (Phase 2)Study completedNCT00077688
What this trial is testing

TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Urothelium

Who this might be right for
Bladder NeoplasmsUreteral NeoplasmsUrethral Neoplasms+1 more
Achieve Life Sciences 44
Not applicableLooking for participantsNCT06394869
What this trial is testing

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Who this might be right for
Hematuria - Cause Not Known
Pacific Edge Limited 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT04579224
What this trial is testing

Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer

Who this might be right for
Metastatic Bladder Urothelial CarcinomaMetastatic Urothelial CarcinomaRefractory Bladder Urothelial Carcinoma+2 more
National Cancer Institute (NCI) 184
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Very early researchStudy completedNCT01240824
What this trial is testing

Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer

Who this might be right for
Bladder Cancer
University of Virginia 3
Next Page